Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;63(6):625-631.
doi: 10.1111/myc.13089. Epub 2020 Apr 28.

Burden of serious fungal infections in the Netherlands

Jochem B Buil  1   2 , Eelco F J Meijer  1   2   3 , David W Denning  4   5   6   7 , Paul E Verweij  1   2   8 , Jacques F Meis  1   2   3   9
Affiliations

Burden of serious fungal infections in the Netherlands

Jochem B Buil et al. Mycoses. 2020 Jun.

Abstract

Background: Fungal diseases have an ever-increasing global disease burden, although regional estimates for specific fungal diseases are often unavailable or dispersed.

Objectives: Here, we report the current annual burden of life-threatening and debilitating fungal diseases in the Netherlands.

Methods: The most recent available epidemiological data, reported incidence and prevalence of fungal diseases were used for calculations.

Results: Overall, we estimate that the annual burden of serious invasive fungal infections in the Netherlands totals 3 185 patients, including extrapulmonary or disseminated cryptococcosis (n = 9), pneumocystis pneumonia (n = 740), invasive aspergillosis (n = 1 283), chronic pulmonary aspergillosis (n = 257), invasive Candida infections (n = 684), mucormycosis (n = 15) and Fusarium keratitis (n = 8). Adding the prevalence of recurrent vulvo-vaginal candidiasis (n = 220 043), allergic bronchopulmonary aspergillosis (n = 13 568) and severe asthma with fungal sensitisation (n = 17 695), the total debilitating burden of fungal disease in the Netherlands is 254 491 patients yearly, approximately 1.5% of the country's population.

Conclusion: We estimated the annual burden of serious fungal infections in the Netherlands at 1.5% of the population based on previously reported modelling of fungal rates for specific populations at risk. With emerging new risk groups and increasing reports on antifungal resistance, surveillance programmes are warranted to obtain more accurate estimates of fungal disease epidemiology and associated morbidity and mortality.

Keywords: aspergillosis; candidemia; cryptococcosis; epidemiology; mucormycosis; pneumocystis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163‐2196. - PMC - PubMed
    1. Centraal Bureau voor de Statistiek . Bevolking; geslacht, leeftijd, generatie en migratieachtergrond. 1 januari. 2019; https://opendata.cbs.nl/#/CBS/nl/dataset/37325/table?dl=2E80B. Accessed December 27, 2019.
    1. Sighem A, Boender T, Wit F, Smit C, Matser A. Monitoring Report 2018. Human Immunodeficiency Virus (HIV) Infection in the Netherlands 2018. https://www.hiv-monitoring.nl/application/files/5815/4279/2363/2018_HIV_.... Accessed December 27, 2019.
    1. van den Broek I, Bregman I, Erkens C, van Hunen R, Schimmel H, de Melker H. Tuberculose in Nederland 2016: Surveillancerapport inclusief rapportage monitoring van interventies. Rijksinstituut voor Volksgezondheid en Milieu RIVM.
    1. Rijksinstituut voor Volksgezondheid en Milieu . Prevalentie en nieuwe gevallen COPD in huisartsenpraktijk. 2018; https://www.volksgezondheidenzorg.info/onderwerp/copd/cijfers-context/hu.... Accessed December 27, 2019.

Supplementary concepts